Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoproteins are proteins that bind to lipids to form lipoproteins, which transport fats—including cholesterol and triglycerides—through the blood, cerebrospinal fluid, and lymph. They have amphipathic properties that allow them to stabilize lipid particles in aqueous environments. Beyond their structural role in forming soluble lipid-protein complexes, apolipoproteins serve as enzyme cofactors essential for lipid metabolism and act as ligands for cell-surface receptors involved in the uptake and clearance of lipids from circulation. Different classes exist—such as ApoA-I in HDL (“good cholesterol”), ApoB in LDL (“bad cholesterol”), and ApoE—which have distinct physiological roles. Genetic variants or dysfunctions can contribute to diseases like atherosclerosis or neurodegenerative conditions such as Alzheimer’s disease through altered lipid handling or signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein (Apo (general), with specific forms such as ApoA-I, ApoB, ApoE, etc.).